West Paces Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56.5K | Buy |
+146
| New | +$54.1K | 0.01% | 263 |
|
|
2025
Q2 | – | Sell |
-104
| Closed | -$45.2K | – | 319 |
|
|
2025
Q1 | $45.2K | Sell |
104
-139
| -57% | -$55.8K | 0.01% | 240 |
|
|
2024
Q4 | $89.6K | Hold |
243
| – | – | 0.02% | 197 |
|
|
2024
Q3 | $126K | Hold |
243
| – | – | 0.03% | 176 |
|
|
2024
Q2 | $132K | Hold |
243
| – | – | 0.03% | 158 |
|
|
2024
Q1 | $126K | Sell |
243
-6
| -2% | -$2.98K | 0.03% | 165 |
|
|
2023
Q4 | $117K | Sell |
249
-8
| -3% | -$3.7K | 0.03% | 162 |
|
|
2023
Q3 | $112K | Sell |
257
-34
| -12% | -$15.4K | 0.04% | 162 |
|
|
2023
Q2 | $129K | Sell |
291
-45
| -13% | -$20.8K | 0.04% | 156 |
|
|
2023
Q1 | $154K | Buy |
336
+52
| +18% | +$24.7K | 0.05% | 139 |
|
|
2022
Q4 | $146K | Buy |
284
+34
| +14% | +$17.3K | 0.05% | 137 |
|
|
2022
Q3 | $114K | Sell |
250
-135
| -35% | -$64.6K | 0.04% | 153 |
|
|
2022
Q2 | $186K | Buy |
385
+262
| +213% | +$130K | 0.06% | 126 |
|
|
2022
Q1 | $60.4K | Sell |
123
-13
| -10% | -$5.94K | 0.02% | 211 |
|
|
2021
Q4 | $63K | Buy |
136
+14
| +11% | +$5.89K | 0.02% | 214 |
|
|
2021
Q3 | $45.5K | Hold |
122
| – | – | 0.02% | 219 |
|
|
2021
Q2 | $46.6K | Sell |
122
-18
| -13% | -$6.88K | 0.02% | 211 |
|
|
2021
Q1 | $50.3K | Hold |
140
| – | – | 0.02% | 191 |
|
|
2020
Q4 | $45K | Hold |
140
| – | – | 0.02% | 189 |
|
|
2020
Q3 | $37.6K | Hold |
140
| – | – | 0.02% | 192 |
|
|
2020
Q2 | $36.8K | Hold |
140
| – | – | 0.02% | 200 |
|
|
2020
Q1 | $31.8K | Sell |
140
-32
| -19% | -$8.72K | 0.02% | 199 |
|
|
2019
Q4 | $51.9K | Hold |
172
| – | – | 0.03% | 186 |
|
|
2019
Q3 | $41.3K | Hold |
172
| – | – | 0.02% | 196 |
|
|
2019
Q2 | $48.5K | Hold |
172
| – | – | 0.03% | 174 |
|
|
2019
Q1 | $49.4K | Hold |
172
| – | – | 0.03% | 176 |
|
|
2018
Q4 | $45.2K | Hold |
172
| – | – | 0.03% | 182 |
|
|
2018
Q3 | $47.1K | Hold |
172
| – | – | 0.03% | 179 |
|
|
2018
Q2 | $40.9K | Buy |
172
+13
| +8% | +$3.01K | 0.03% | 189 |
|
|
2018
Q1 | $34.9K | Hold |
159
| – | – | 0.03% | 198 |
|
|
2017
Q4 | $35.8K | Hold |
159
| – | – | 0.03% | 208 |
|
|
2017
Q3 | $30.2K | Hold |
159
| – | – | 0.02% | 227 |
|
|
2017
Q2 | $29.9K | Hold |
159
| – | – | 0.02% | 226 |
|
|
2017
Q1 | $26.3K | Sell |
159
-1
| -0.6% | -$159 | 0.02% | 228 |
|
|
2016
Q4 | $23K | Buy |
+160
| New | +$21.4K | 0.02% | 247 |
|
Other funds holding ELV
West Paces Advisors's ELV Position: Q2 2026 in Review
West Paces Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 146 shares worth $56.5K. The stake represents 0.01% of the portfolio and ranks #263 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in ELV as recently as Q1 2025.
West Paces Advisors first reported a position in ELV in Q4 2016 and has held it in 35 quarters since. The position peaked at $186K in Q2 2022. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- West Paces Advisors held 146 shares of Elevance Health worth $56.5K as of Q2 2026.
- Elevance Health was a new West Paces Advisors position in Q2 2026.
- Elevance Health made up 0.01% of West Paces Advisors's portfolio in Q2 2026, its #263 holding.
- West Paces Advisors first reported a position in Elevance Health in Q4 2016 and has held it in 35 quarters since.
- West Paces Advisors's Elevance Health position peaked at $186K in Q2 2022.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.